- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02355366
Family Focused Therapy for Teens at Risk for Bipolar Disorder
January 18, 2019 updated by: Dr. Benjamin Goldstein, Sunnybrook Health Sciences Centre
Family Focused Therapy (FFT) for Adolescents at Familial Risk for Bipolar
The present study aims to examine the effects of a 4 month, family focused therapy (FFT) intervention on the 1 year course of mood symptoms in offspring of parents with bipolar disorder (BD).
The study will also examine the level of expressed emotion among families and how this impacts on FFT treatment outcomes.
This study seeks to replicate a previous study by Miklowitz, Schneck, Singh, Taylor, George and colleagues (2013), which demonstrated the efficacy of FFT among BD offspring.
Importantly, the present study will introduce biological measures that predict and reflect improvement in symptoms and expressed emotion.
These markers reflect stress-related biological systems and include saliva samples to ascertain cortisol, interleukin-6 (IL-6) and salivary alpha amylase (sAA).
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Children of parents with bipolar disorder (BD) have increased risk of developing BD themselves.
BD in youth is associated with increased risk for suicidality, psychosis, substance abuse and compromised psychosocial functioning.
In addition, offspring of parents with BD have an increased vulnerability for developing other psychopathology (e.g.
major depression).
At present, research examining early intervention and treatment for this high risk population is limited.
However, a recent study in symptomatic youth at risk for BD indicated that participation in a family focused therapy (FFT) intervention led to positive treatment outcomes.
The present study aims to examine the effects of FFT in BD offspring in comparison to a brief educational treatment.
Specifically, this study will examine whether FFT can have protective effects on individuals' mood symptoms and functioning by targeting the family environment.
We will expand upon previous research by also measuring biological markers of stress (i.e., cortisol levels) and changes in family functioning over time.
With this knowledge, the results of this study may help to shed light on the importance of early intervention and improve preventative treatment options for youth at high-risk for bipolar disorder.
Study Type
Interventional
Enrollment (Actual)
2
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M4N 3M5
- SunnyBrook Health Sciences Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
11 years to 17 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- English-speaking males and females of any race/ethnicity
- 13-19 years of age
- Have at least 1 biological parent who meets diagnostic criteria for bipolar disorder (BD) type I or II, based on the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I)
- Adolescent is experiencing current, significant mood symptoms indicated by a psychiatric status rating (PSR) score of 3
- At least 1 parent/primary caregiver is available to attend sessions.
All participants will complete rigorous diagnostic interviews to ensure that they meet these requirements.
Exclusion Criteria:
- Unable to provide informed consent (e.g., severe psychosis, developmental delay)
- Have met the DSM-IV criteria (based on the Schedule for Affective Disorders and Schizophrenia for School Age Children, Present and Life Version - K-SADS-PL), for substance dependence in the past 3 months (excluding nicotine dependence)
- Are victims of current sexual or physical abuse by parents or live among domestic violence
- For offspring, already meet criteria for bipolar disorder (BD) type I or II.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Family Focused Therapy (FFT)
Participants will receive Family-Focused Therapy (FFT).
It will consist of twelve, 1-hour long sessions, over a period of 4 months.
The 12 sessions will include psychoeducation (sessions 1-4), training in communication enhancement (sessions 5-8) and training in relation to problem-solving skills (sessions 9-12).
|
Family Focused Therapy is a manual-based, psycho-educational intervention which is designed to reduce intra-familial stress, conflict, and affective arousal by enhancing communication and problem solving skills among families who are affected by bipolar disorder (Miklowitz et al., 2013).
It concentrates on skills relevant to managing the prodromal stages of bipolar disorder, such as mood monitoring, reducing family conflict, improving problem solving, stabilizing daily routines and regulating sleep/wake cycles (Miklowitz, 2012).
Other Names:
|
Active Comparator: Brief Educational Treatment
Participants will be receive 1-2 educational sessions which will include diagnostic feedback, recommendations for further treatment and crisis intervention if required.
|
Brief Educational Treatment will consist of 1 - 2 sessions involving both parents and adolescents; it will consist of diagnostic feedback following the adolescent's baseline assessment.
It will provide families with information and strategies on tracking and managing adolescent mood disorders.
Additionally, ongoing medication management and crisis family sessions will be available if required.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
KSADS Mania Rating Scale (KMRS)
Time Frame: Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)
|
Measures symptom severity.
|
Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)
|
KSADS Depression Section (KDRS)
Time Frame: Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)
|
Measures symptom severity.
|
Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)
|
Adolescent Longitudinal Interval Follow-up Evaluation (A-LIFE)
Time Frame: Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)
|
Used to track symptom severity, treatment (both psychosocial and psychotropic), self-injurious/suicidal behavior and psychosocial functioning over time.
|
Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)
|
The Family Environment Scale (FES)
Time Frame: Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)
|
Examines each family member's perceptions of the family in three ways-as it is (real), as it would be in a perfect situation (ideal) and as it will probably be in new situations (expected).
|
Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)
|
Family Adaptability & Cohesion & Adaptability Scale (FACES)
Time Frame: Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)
|
Evaluate the adaptability and cohesion dimensions in family interactions.
|
Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)
|
Conflict Behaviour Questionnaire (CBQ)
Time Frame: Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)
|
Measures conflict and negative communication between parents and adolescents.
|
Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)
|
Issues Checklist
Time Frame: Change from baseline to endpoint (assessed at 0, 4 and 12 months)
|
Measures potential areas of conflict between parents and adolescents.
|
Change from baseline to endpoint (assessed at 0, 4 and 12 months)
|
Cortisol
Time Frame: Change from baseline to endpoint (assessed at 0, 4, and 12 months)
|
Stress-related biomarker obtained through saliva samples.
|
Change from baseline to endpoint (assessed at 0, 4, and 12 months)
|
Interleukin 6 (IL-6)
Time Frame: Change from baseline to endpoint (assessed at weeks 0, 4, and 12 months)
|
Stress-related biomarker obtained through saliva samples.
|
Change from baseline to endpoint (assessed at weeks 0, 4, and 12 months)
|
Alpha Amylase
Time Frame: Change from baseline to endpoint (assessed at 0, 4, and 12 months)
|
Stress-related biomarker obtained through saliva samples.
|
Change from baseline to endpoint (assessed at 0, 4, and 12 months)
|
Five Minute Speech Sample
Time Frame: Change from baseline to endpoint (assessed at 0, 4, and 12 months)
|
Assesses level of expressed emotion (EE) within the parental household.
|
Change from baseline to endpoint (assessed at 0, 4, and 12 months)
|
Emotional Response to Conflict Scale (ERCS)
Time Frame: Change from baseline to endpoint (assessed at 0, 4 and 12 months)
|
Assesses individuals' emotional responses to a brief, laboratory based, conflict negotiation task.
|
Change from baseline to endpoint (assessed at 0, 4 and 12 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Children Global Assessment Scale
Time Frame: Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)
|
Quantifies overall level of functioning for a child or adolescent during a specified time period.
|
Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)
|
Anthromorphic Data
Time Frame: Change from baseline to endpoint (Assessed at weeks 0 and 12 months)
|
Measures height, weight, body mass index, & blood pressure.
|
Change from baseline to endpoint (Assessed at weeks 0 and 12 months)
|
Working Alliance Inventory Short-Revised (WAI-SR)
Time Frame: Change from baseline to endpoint. For FFT Group: Assessed after therapy sessions 1, 4, 8 & 12. For Education Control Group: Assessed after therapy sessions 1 & 2.
|
Measures therapeutic alliance.
|
Change from baseline to endpoint. For FFT Group: Assessed after therapy sessions 1, 4, 8 & 12. For Education Control Group: Assessed after therapy sessions 1 & 2.
|
General Information Sheet
Time Frame: Baseline
|
Demographics
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Miklowitz DJ, Schneck CD, Singh MK, Taylor DO, George EL, Cosgrove VE, Howe ME, Dickinson LM, Garber J, Chang KD. Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapy. J Am Acad Child Adolesc Psychiatry. 2013 Feb;52(2):121-31. doi: 10.1016/j.jaac.2012.10.007. Epub 2013 Jan 2.
- Miklowitz DJ. Family-focused treatment for children and adolescents with bipolar disorder. Isr J Psychiatry Relat Sci. 2012;49(2):95-101.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2015
Primary Completion (Actual)
November 26, 2018
Study Completion (Actual)
November 26, 2018
Study Registration Dates
First Submitted
January 30, 2015
First Submitted That Met QC Criteria
February 3, 2015
First Posted (Estimate)
February 4, 2015
Study Record Updates
Last Update Posted (Actual)
January 22, 2019
Last Update Submitted That Met QC Criteria
January 18, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 404-2014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bipolar Disorder
-
ProgenaBiomeRecruitingBipolar Disorder | Bipolar I Disorder | Bipolar II Disorder | Bipolar Type I Disorder | Bipolar Disorder Mild | Bipolar Disorder Moderate | Bipolar Disorder SevereUnited States
-
Region StockholmKarolinska InstitutetRecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II Disorder | Bipolar Affective Disorder; Remission in | Bipolar Affective Disorder, Currently Depressed, ModerateSweden
-
Rush University Medical CenterThe Ryan Licht Sang Bipolar FoundationCompletedBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar Disorder I | Bipolar Affective DisorderUnited States
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionCompletedBipolar I Disorder | Bipolar II Disorder | Bipolar Disorder NOSUnited States
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Hospital Moinhos de VentoActive, not recruitingBipolar Disorder | Bipolar Depression | Major Depressive Disorder | Bipolar I Disorder | Affective Disorder | Bipolar II DisorderBrazil
-
Medical University of South CarolinaMilken InstituteCompletedBipolar Disorder | Bipolar I Disorder | Bipolar II DisorderUnited States
-
Joshua RosenblatRecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II DisorderCanada
-
Mayo ClinicCompletedMajor Depressive Disorder, Bipolar I and Bipolar IIUnited States
-
Joshua RosenblatRecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II DisorderCanada
-
Myriad Genetic Laboratories, Inc.University of MinnesotaCompletedMajor Depressive Disorder, Bipolar I and Bipolar IIUnited States
Clinical Trials on Family-Focused Therapy
-
University Hospital, MontpellierTerminated
-
Dokuz Eylul UniversityCompletedBipolar Disorder | Psychosis | Family Relations | Mental Disorder in AdolescenceTurkey
-
Stanford UniversityUniversity of ChicagoCompleted
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)CompletedPsychosisUnited States, Canada
-
VU University of AmsterdamUtrecht UniversityRecruiting
-
University of GuelphRecruitingDepression | Anxiety | Behavior ProblemCanada
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Social Phobia | Separation Anxiety DisorderUnited States
-
University of California, Los AngelesStanford University; University of Colorado, BoulderCompletedBipolar Disorder | Major Depressive DisorderUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Monash University; Beth Israel Medical Center; Calvary Hospital, Bronx, NYActive, not recruiting
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)CompletedBipolar DisorderUnited States